Q2 2023 Holdings
Filed 2023-08-14 | 11 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alkermes PLC(ALKS) | SHS | G01767105 | $439.5M | 14,040,000 | 43.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $183.2M | 643,000 | 18.2% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $174.4M | 16,390,000 | 17.4% |
| Innoviva Inc(INVA) | COM | 45781M101 | $92.6M | 7,277,000 | 9.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $70.9M | 920,400 | 7.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $21.8M | 231,300 | 2.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $8.7M | 2,632,900 | 0.9% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $5.8M | 4,910,000 | 0.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.5M | 775,000 | 0.5% |
| VOR Biopharma Inc | COM | 929033108 | $1.9M | 618,000 | 0.2% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $272.2K | 185,183 | 0.0% |